| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.05e-15 | 26 | 28 | 7 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.06e-13 | 52 | 28 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.59e-11 | 171 | 28 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN10A SLC44A2 CACNA1S CACNA1H CACNA1G SLC43A3 SLC13A2 SLC16A2 SCN4A SLC22A10 SCN5A SCN7A TPCN1 | 1.63e-09 | 1180 | 28 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SCN10A SLC44A2 CACNA1S CACNA1H CACNA1G SLC43A3 SLC13A2 SLC16A2 SCN4A SLC22A10 SCN5A SCN7A TPCN1 | 4.78e-09 | 1289 | 28 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 8.69e-09 | 465 | 28 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.61e-08 | 343 | 28 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 1.13e-07 | 627 | 28 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.52e-07 | 459 | 28 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 1.85e-07 | 664 | 28 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | channel activity | 4.23e-07 | 525 | 28 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.29e-07 | 526 | 28 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 5.63e-07 | 758 | 28 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 8.22e-07 | 793 | 28 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 8.90e-07 | 14 | 28 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.21e-06 | 184 | 28 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 5.68e-06 | 3 | 28 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.78e-06 | 334 | 28 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.83e-05 | 6 | 28 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.02e-05 | 129 | 28 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.60e-05 | 46 | 28 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.59e-05 | 151 | 28 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.15e-04 | 182 | 28 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.89e-04 | 207 | 28 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.92e-04 | 208 | 28 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.67e-04 | 90 | 28 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.94e-04 | 93 | 28 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 4.71e-04 | 23 | 28 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.04e-04 | 293 | 28 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 7.32e-04 | 296 | 28 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.21e-03 | 884 | 28 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.23e-03 | 152 | 28 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.76e-03 | 172 | 28 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 2.16e-03 | 1353 | 28 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.50e-03 | 53 | 28 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.18e-03 | 477 | 28 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.69e-03 | 73 | 28 | 2 | GO:0170055 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.49e-02 | 133 | 28 | 2 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.64e-02 | 140 | 28 | 2 | GO:0001653 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.44e-10 | 208 | 28 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.16e-09 | 36 | 28 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.23e-09 | 275 | 28 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.48e-09 | 93 | 28 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.27e-08 | 217 | 28 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.63e-08 | 127 | 28 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.94e-08 | 62 | 28 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 2.10e-08 | 63 | 28 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.97e-08 | 153 | 28 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 8.37e-08 | 167 | 28 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.08e-07 | 87 | 28 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | action potential | 2.50e-07 | 201 | 28 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 2.67e-07 | 10 | 28 | 3 | GO:0060371 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.84e-07 | 112 | 28 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN10A CACNA1S CACNA1H CACNA1G MCHR1 SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 4.05e-07 | 1000 | 28 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | muscle system process | 4.53e-07 | 547 | 28 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 4.89e-07 | 12 | 28 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 4.89e-07 | 12 | 28 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.64e-07 | 121 | 28 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | muscle contraction | 8.15e-07 | 400 | 28 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN10A CACNA1S CACNA1H CACNA1G MCHR1 SLC13A2 SCN4A SLC22A10 SCN5A SCN7A TPCN1 | 8.22e-07 | 1374 | 28 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.01e-06 | 15 | 28 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN10A CACNA1S CACNA1H CACNA1G MCHR1 SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 1.54e-06 | 1157 | 28 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 2.20e-06 | 922 | 28 | 9 | GO:0098662 |
| GeneOntologyBiologicalProcess | heart contraction | 2.49e-06 | 298 | 28 | 6 | GO:0060047 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 2.62e-06 | 942 | 28 | 9 | GO:0098655 |
| GeneOntologyBiologicalProcess | heart process | 3.07e-06 | 309 | 28 | 6 | GO:0003015 | |
| GeneOntologyBiologicalProcess | circulatory system process | 4.05e-06 | 733 | 28 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 4.91e-06 | 1017 | 28 | 9 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 7.01e-06 | 202 | 28 | 5 | GO:0006937 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 7.46e-06 | 559 | 28 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN10A CACNA1S CACNA1H CACNA1G SLC13A2 SCN4A SCN5A SCN7A TPCN1 | 1.04e-05 | 1115 | 28 | 9 | GO:0034220 |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.30e-05 | 34 | 28 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.32e-05 | 230 | 28 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 1.47e-05 | 111 | 28 | 4 | GO:0006942 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.77e-05 | 5 | 28 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.95e-05 | 648 | 28 | 7 | GO:0008015 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 2.66e-05 | 6 | 28 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 3.72e-05 | 7 | 28 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 3.72e-05 | 7 | 28 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.72e-05 | 48 | 28 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.72e-05 | 48 | 28 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.88e-05 | 142 | 28 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.88e-05 | 142 | 28 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 6.11e-05 | 317 | 28 | 5 | GO:0090257 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 6.92e-05 | 59 | 28 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 7.65e-05 | 61 | 28 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 7.94e-05 | 10 | 28 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 7.94e-05 | 10 | 28 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | choline transport | 7.94e-05 | 10 | 28 | 2 | GO:0015871 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 9.70e-05 | 11 | 28 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 1.85e-04 | 15 | 28 | 2 | GO:0086069 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 2.35e-04 | 89 | 28 | 3 | GO:0055117 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.13e-04 | 98 | 28 | 3 | GO:0070509 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.32e-04 | 100 | 28 | 3 | GO:0061337 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion-dependent exocytosis | 3.33e-04 | 20 | 28 | 2 | GO:0045956 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 3.38e-04 | 249 | 28 | 4 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of system process | 3.83e-04 | 734 | 28 | 6 | GO:0044057 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 4.42e-04 | 23 | 28 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 5.51e-04 | 509 | 28 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | organic anion transport | 5.81e-04 | 515 | 28 | 5 | GO:0015711 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 6.22e-04 | 124 | 28 | 3 | GO:0007218 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 6.98e-04 | 129 | 28 | 3 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 9.30e-04 | 326 | 28 | 4 | GO:1903522 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.20e-03 | 912 | 28 | 6 | GO:0030029 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 1.34e-03 | 40 | 28 | 2 | GO:0003161 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 1.40e-03 | 164 | 28 | 3 | GO:0043500 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 1.41e-03 | 41 | 28 | 2 | GO:0086091 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 1.55e-03 | 43 | 28 | 2 | GO:0086004 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 1.70e-03 | 45 | 28 | 2 | GO:0017158 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.83e-03 | 392 | 28 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.14e-03 | 1395 | 28 | 7 | GO:0007186 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.16e-03 | 410 | 28 | 4 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.20e-03 | 412 | 28 | 4 | GO:0015849 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 2.35e-03 | 53 | 28 | 2 | GO:1903115 | |
| GeneOntologyBiologicalProcess | import into cell | 2.76e-03 | 1074 | 28 | 6 | GO:0098657 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 2.80e-03 | 58 | 28 | 2 | GO:0007520 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 2.94e-03 | 213 | 28 | 3 | GO:0015718 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.10e-03 | 217 | 28 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 3.61e-03 | 66 | 28 | 2 | GO:1903307 | |
| GeneOntologyBiologicalProcess | striated muscle adaptation | 4.40e-03 | 73 | 28 | 2 | GO:0014888 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine metabolic process | 5.01e-03 | 78 | 28 | 2 | GO:0046470 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.99e-14 | 17 | 28 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.51e-12 | 29 | 28 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.01e-08 | 235 | 28 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.41e-08 | 378 | 28 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.91e-07 | 523 | 28 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 4.26e-07 | 550 | 28 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.14e-05 | 46 | 28 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 6.08e-05 | 785 | 28 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.26e-04 | 73 | 28 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | membrane protein complex | 5.80e-04 | 1498 | 28 | 8 | GO:0098796 | |
| GeneOntologyCellularComponent | sarcolemma | 2.05e-03 | 190 | 28 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | non-motile cilium | 2.24e-03 | 196 | 28 | 3 | GO:0097730 | |
| HumanPheno | Hypokalemia | 3.58e-06 | 79 | 8 | 4 | HP:0002900 | |
| HumanPheno | Reduced systolic function | 4.44e-06 | 23 | 8 | 3 | HP:0006673 | |
| HumanPheno | Malignant hyperthermia | 6.50e-06 | 26 | 8 | 3 | HP:0002047 | |
| HumanPheno | Abnormal blood potassium concentration | 1.50e-05 | 113 | 8 | 4 | HP:0011042 | |
| HumanPheno | Episodic hypokalemia | 3.23e-05 | 6 | 8 | 2 | HP:0012726 | |
| HumanPheno | Episodic flaccid weakness | 4.52e-05 | 7 | 8 | 2 | HP:0003752 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 5.12e-05 | 154 | 8 | 4 | HP:0010930 | |
| HumanPheno | Late-onset proximal muscle weakness | 6.02e-05 | 8 | 8 | 2 | HP:0003694 | |
| HumanPheno | Prolonged QT interval | 6.08e-05 | 54 | 8 | 3 | HP:0001657 | |
| HumanPheno | Respiratory paralysis | 7.73e-05 | 9 | 8 | 2 | HP:0002203 | |
| HumanPheno | Postprandial hyperglycemia | 7.73e-05 | 9 | 8 | 2 | HP:0011998 | |
| HumanPheno | Periodic hypokalemic paresis | 7.73e-05 | 9 | 8 | 2 | HP:0008153 | |
| HumanPheno | Adrenocortical adenoma | 7.73e-05 | 9 | 8 | 2 | HP:0008256 | |
| HumanPheno | Impaired myocardial contractility | 9.65e-05 | 10 | 8 | 2 | HP:0006670 | |
| HumanPheno | Apneic episodes in infancy | 9.65e-05 | 10 | 8 | 2 | HP:0005949 | |
| HumanPheno | Ventricular fibrillation | 9.66e-05 | 63 | 8 | 3 | HP:0001663 | |
| HumanPheno | Abnormal QT interval | 1.01e-04 | 64 | 8 | 3 | HP:0031547 | |
| HumanPheno | Periodic paralysis | 1.18e-04 | 11 | 8 | 2 | HP:0003768 | |
| HumanPheno | Ventricular tachycardia | 1.27e-04 | 69 | 8 | 3 | HP:0004756 | |
| HumanPheno | Exercise-induced muscle fatigue | 1.41e-04 | 12 | 8 | 2 | HP:0009020 | |
| HumanPheno | Adrenocortical abnormality | 1.76e-04 | 77 | 8 | 3 | HP:0000849 | |
| HumanPheno | Second degree atrioventricular block | 2.24e-04 | 15 | 8 | 2 | HP:0011706 | |
| HumanPheno | Muscle flaccidity | 2.24e-04 | 15 | 8 | 2 | HP:0010547 | |
| HumanPheno | Atrioventricular block | 3.09e-04 | 93 | 8 | 3 | HP:0001678 | |
| HumanPheno | Heart block | 3.09e-04 | 93 | 8 | 3 | HP:0001668 | |
| HumanPheno | Bradycardia | 3.61e-04 | 98 | 8 | 3 | HP:0001662 | |
| HumanPheno | Increased muscle fatiguability | 3.64e-04 | 19 | 8 | 2 | HP:0003750 | |
| HumanPheno | Abnormal cardiac exercise stress test | 3.64e-04 | 19 | 8 | 2 | HP:0500018 | |
| HumanPheno | Trifascicular block | 4.91e-04 | 22 | 8 | 2 | HP:0011715 | |
| HumanPheno | Increased intramyocellular lipid droplets | 5.37e-04 | 23 | 8 | 2 | HP:0012240 | |
| HumanPheno | ST segment elevation | 6.36e-04 | 25 | 8 | 2 | HP:0012251 | |
| HumanPheno | Abnormal PR interval | 6.36e-04 | 25 | 8 | 2 | HP:0031593 | |
| HumanPheno | Torsade de pointes | 6.36e-04 | 25 | 8 | 2 | HP:0001664 | |
| HumanPheno | Supraventricular tachycardia | 6.55e-04 | 120 | 8 | 3 | HP:0004755 | |
| HumanPheno | Abnormality of masticatory muscle | 7.43e-04 | 27 | 8 | 2 | HP:0410011 | |
| HumanPheno | Paroxysmal ventricular tachycardia | 7.43e-04 | 27 | 8 | 2 | HP:0004751 | |
| HumanPheno | Neoplasm of the adrenal cortex | 7.99e-04 | 28 | 8 | 2 | HP:0100641 | |
| HumanPheno | Abnormal atrioventricular conduction | 8.47e-04 | 131 | 8 | 3 | HP:0005150 | |
| HumanPheno | Atrioventricular nodal disease | 8.47e-04 | 131 | 8 | 3 | HP:0005142 | |
| HumanPheno | Premature ventricular contraction | 8.58e-04 | 29 | 8 | 2 | HP:0006682 | |
| HumanPheno | Sick sinus syndrome | 8.58e-04 | 29 | 8 | 2 | HP:0011704 | |
| HumanPheno | Prolonged QTc interval | 8.58e-04 | 29 | 8 | 2 | HP:0005184 | |
| HumanPheno | Supraventricular arrhythmia | 9.05e-04 | 134 | 8 | 3 | HP:0005115 | |
| HumanPheno | Sinus bradycardia | 9.19e-04 | 30 | 8 | 2 | HP:0001688 | |
| HumanPheno | Abnormal EKG | 9.45e-04 | 136 | 8 | 3 | HP:0003115 | |
| HumanPheno | Heart block | 9.45e-04 | 136 | 8 | 3 | HP:0012722 | |
| HumanPheno | Abnormality of jaw muscles | 9.81e-04 | 31 | 8 | 2 | HP:0045037 | |
| HumanPheno | Abnormal adrenal morphology | 1.14e-03 | 145 | 8 | 3 | HP:0011732 | |
| HumanPheno | Abnormal endocrine morphology | 1.14e-03 | 145 | 8 | 3 | HP:0031071 | |
| HumanPheno | Myotonia | 1.18e-03 | 34 | 8 | 2 | HP:0002486 | |
| HumanPheno | Abnormal T-wave | 1.40e-03 | 37 | 8 | 2 | HP:0005135 | |
| HumanPheno | Abnormal ST segment | 1.55e-03 | 39 | 8 | 2 | HP:0012249 | |
| HumanPheno | Fatty replacement of skeletal muscle | 1.55e-03 | 39 | 8 | 2 | HP:0012548 | |
| HumanPheno | Increased muscle lipid content | 1.63e-03 | 40 | 8 | 2 | HP:0009058 | |
| HumanPheno | Hyperkalemia | 1.63e-03 | 40 | 8 | 2 | HP:0002153 | |
| HumanPheno | Cardiac conduction abnormality | 1.72e-03 | 167 | 8 | 3 | HP:0031546 | |
| HumanPheno | Urinary incontinence | 1.93e-03 | 174 | 8 | 3 | HP:0000020 | |
| HumanPheno | Urinary or fecal incontinence | 1.93e-03 | 174 | 8 | 3 | HP:0007147 | |
| HumanPheno | Impaired continence | 1.96e-03 | 175 | 8 | 3 | HP:0031064 | |
| HumanPheno | First degree atrioventricular block | 1.98e-03 | 44 | 8 | 2 | HP:0011705 | |
| HumanPheno | Abnormal blood cation concentration | 2.05e-03 | 401 | 8 | 4 | HP:0010929 | |
| HumanPheno | Abnormal cardiological findings | 2.06e-03 | 178 | 8 | 3 | HP:0003114 | |
| HumanPheno | Abnormal cardiac test | 2.10e-03 | 179 | 8 | 3 | HP:0500015 | |
| HumanPheno | Abnormal test result | 2.17e-03 | 181 | 8 | 3 | HP:0500014 | |
| HumanPheno | Neoplasm of the adrenal gland | 2.25e-03 | 47 | 8 | 2 | HP:0100631 | |
| HumanPheno | Impairment of activities of daily living | 2.42e-03 | 188 | 8 | 3 | HP:0031058 | |
| HumanPheno | Tachycardia | 2.45e-03 | 189 | 8 | 3 | HP:0001649 | |
| HumanPheno | Axial muscle weakness | 2.55e-03 | 50 | 8 | 2 | HP:0003327 | |
| HumanPheno | Second trimester onset | 2.65e-03 | 51 | 8 | 2 | HP:0034198 | |
| HumanPheno | Abnormal axial muscle morphology | 2.75e-03 | 52 | 8 | 2 | HP:0040286 | |
| HumanPheno | Abnormal muscle tissue metabolite concentration | 2.97e-03 | 54 | 8 | 2 | HP:0034370 | |
| HumanPheno | Abnormal blood ion concentration | 3.03e-03 | 445 | 8 | 4 | HP:0003111 | |
| HumanPheno | Pes valgus | 3.19e-03 | 56 | 8 | 2 | HP:0008081 | |
| HumanPheno | Abnormality of cardiac conduction | 3.21e-03 | 452 | 8 | 4 | HP:0001665 | |
| HumanPheno | Right bundle branch block | 3.30e-03 | 57 | 8 | 2 | HP:0011712 | |
| HumanPheno | Fatigable weakness of respiratory muscles | 3.41e-03 | 58 | 8 | 2 | HP:0030196 | |
| HumanPheno | Centrally nucleated skeletal muscle fibers | 3.65e-03 | 60 | 8 | 2 | HP:0003687 | |
| HumanPheno | Mildly elevated creatine kinase | 4.14e-03 | 64 | 8 | 2 | HP:0008180 | |
| MousePheno | thin ribs | 9.26e-05 | 9 | 23 | 2 | MP:0004674 | |
| MousePheno | prolonged PQ interval | 1.16e-04 | 10 | 23 | 2 | MP:0011953 | |
| MousePheno | impaired ability to fire action potentials | 2.00e-04 | 13 | 23 | 2 | MP:0002578 | |
| MousePheno | sinus bradycardia | 2.33e-04 | 14 | 23 | 2 | MP:0010637 | |
| Domain | Channel_four-helix_dom | 1.34e-14 | 57 | 28 | 8 | IPR027359 | |
| Domain | - | 1.34e-14 | 57 | 28 | 8 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 4.22e-12 | 114 | 28 | 8 | IPR005821 | |
| Domain | Ion_trans | 4.22e-12 | 114 | 28 | 8 | PF00520 | |
| Domain | Na_channel_asu | 8.43e-10 | 10 | 28 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 8.43e-10 | 10 | 28 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 8.43e-10 | 10 | 28 | 4 | PF06512 | |
| Domain | VDCCAlpha1 | 3.60e-07 | 10 | 28 | 3 | IPR002077 | |
| Domain | VDCC_T_a1 | 6.50e-06 | 3 | 28 | 2 | IPR005445 | |
| Domain | IQ_motif_EF-hand-BS | 9.45e-06 | 90 | 28 | 4 | IPR000048 | |
| Domain | MFS | 2.05e-04 | 77 | 28 | 3 | IPR011701 | |
| Domain | MFS_1 | 2.05e-04 | 77 | 28 | 3 | PF07690 | |
| Domain | IQ | 2.38e-04 | 81 | 28 | 3 | SM00015 | |
| Domain | IQ | 3.58e-04 | 93 | 28 | 3 | PS50096 | |
| Domain | MFS_dom | 1.04e-03 | 134 | 28 | 3 | IPR020846 | |
| Domain | GPCR_Rhodpsn_7TM | 2.90e-03 | 670 | 28 | 5 | IPR017452 | |
| Domain | 7tm_1 | 3.03e-03 | 677 | 28 | 5 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 3.19e-03 | 685 | 28 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.31e-03 | 691 | 28 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.33e-03 | 692 | 28 | 5 | IPR000276 | |
| Domain | IQ | 5.05e-03 | 71 | 28 | 2 | PF00612 | |
| Domain | EF-hand-dom_pair | 8.85e-03 | 287 | 28 | 3 | IPR011992 | |
| Domain | MFS | 1.14e-02 | 108 | 28 | 2 | PS50850 | |
| Domain | Olfact_rcpt | 2.05e-02 | 393 | 28 | 3 | IPR000725 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.97e-07 | 31 | 24 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.25e-07 | 32 | 24 | 4 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.98e-07 | 203 | 24 | 6 | M5485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.51e-06 | 23 | 24 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 9.73e-06 | 25 | 24 | 3 | M47948 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.42e-05 | 575 | 24 | 7 | M29853 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.77e-05 | 42 | 24 | 3 | M7169 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.80e-05 | 121 | 24 | 4 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 6.36e-05 | 130 | 24 | 4 | M27454 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.61e-04 | 63 | 24 | 3 | M11187 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 2.20e-04 | 70 | 24 | 3 | MM14984 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.75e-04 | 190 | 24 | 4 | MM15687 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 3.29e-04 | 367 | 24 | 5 | M48346 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.40e-03 | 43 | 24 | 2 | M1429 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.30e-03 | 178 | 24 | 3 | M2890 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.54e-11 | 139 | 28 | 7 | 16985003 | |
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 12900400 | ||
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 28330839 | ||
| Pubmed | 3.91e-08 | 9 | 28 | 3 | 16382098 | ||
| Pubmed | 3.91e-08 | 9 | 28 | 3 | 16382099 | ||
| Pubmed | 2.60e-07 | 16 | 28 | 3 | 21266775 | ||
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 6.25e-07 | 2 | 28 | 2 | 24642470 | |
| Pubmed | Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. | 6.25e-07 | 2 | 28 | 2 | 19118277 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23436820 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 14988077 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21079360 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11834499 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 35759432 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21622683 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31042060 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 30714145 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22886848 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15047701 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20685979 | ||
| Pubmed | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | 6.25e-07 | 2 | 28 | 2 | 15072700 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29082441 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 34608571 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 6.25e-07 | 2 | 28 | 2 | 24998131 | |
| Pubmed | Genotype and phenotype analysis of patients with sporadic periodic paralysis. | 6.25e-07 | 2 | 28 | 2 | 21841462 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22574369 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 6.25e-07 | 2 | 28 | 2 | 30944319 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24360055 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31292628 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 6.25e-07 | 2 | 28 | 2 | 21438841 | |
| Pubmed | Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. | 6.25e-07 | 2 | 28 | 2 | 26252573 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22469755 | ||
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 6.25e-07 | 2 | 28 | 2 | 22808078 | |
| Pubmed | The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function. | 6.25e-07 | 2 | 28 | 2 | 25600872 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32330377 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24327205 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20301512 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.87e-06 | 3 | 28 | 2 | 23488970 | |
| Pubmed | Fibromodulin modulates myoblast differentiation by controlling calcium channel. | 1.87e-06 | 3 | 28 | 2 | 29913145 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24966091 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 26488564 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 31919478 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25825486 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.87e-06 | 3 | 28 | 2 | 18591418 | |
| Pubmed | Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin. | 1.87e-06 | 3 | 28 | 2 | 15746172 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.87e-06 | 3 | 28 | 2 | 11230107 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11897840 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28846697 | ||
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 1.87e-06 | 3 | 28 | 2 | 21084288 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 33547341 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 37739992 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.87e-06 | 3 | 28 | 2 | 28972185 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32555258 | ||
| Pubmed | Mutation spectrum and health status in skeletal muscle channelopathies in Japan. | 1.87e-06 | 3 | 28 | 2 | 32660787 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11927664 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 22572848 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20038812 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25998140 | ||
| Pubmed | Genome-wide association studies of the PR interval in African Americans. | 3.75e-06 | 4 | 28 | 2 | 21347284 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 31800012 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 3.75e-06 | 4 | 28 | 2 | 21788606 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10198179 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 3.75e-06 | 4 | 28 | 2 | 28165634 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28655554 | ||
| Pubmed | Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. | 6.24e-06 | 5 | 28 | 2 | 22706305 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 12060068 | ||
| Pubmed | Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. | 6.24e-06 | 5 | 28 | 2 | 23463857 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 23872634 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 6.24e-06 | 5 | 28 | 2 | 29720258 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 17724025 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 23139255 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 34478646 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 9412493 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.74e-05 | 8 | 28 | 2 | 12761855 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 15746173 | ||
| Pubmed | Trait-associated noncoding variant regions affect TBX3 regulation and cardiac conduction. | 2.80e-05 | 10 | 28 | 2 | 32672536 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 24778262 | ||
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 3.42e-05 | 11 | 28 | 2 | 27766308 | |
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 20062060 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 32492036 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 15123669 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 25599332 | ||
| Pubmed | Several common variants modulate heart rate, PR interval and QRS duration. | 5.65e-05 | 14 | 28 | 2 | 20062063 | |
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 25035420 | ||
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 36709857 | ||
| Pubmed | Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. | 8.44e-05 | 17 | 28 | 2 | 21076409 | |
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 24850809 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 8.44e-05 | 17 | 28 | 2 | 27725084 | |
| Pubmed | An enhancer cluster controls gene activity and topology of the SCN5A-SCN10A locus in vivo. | 9.49e-05 | 18 | 28 | 2 | 31666509 | |
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 27180262 | ||
| Pubmed | The formation and function of the cardiac conduction system. | 1.30e-04 | 21 | 28 | 2 | 26786210 | |
| Pubmed | Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit. | 1.30e-04 | 21 | 28 | 2 | 28302382 | |
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 16637659 | ||
| Pubmed | 1.71e-04 | 24 | 28 | 2 | 20301690 | ||
| Pubmed | 2.68e-04 | 30 | 28 | 2 | 39366945 | ||
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 2.86e-04 | 31 | 28 | 2 | 17473172 | |
| Pubmed | 3.45e-04 | 34 | 28 | 2 | 26378152 | ||
| Pubmed | 3.73e-04 | 430 | 28 | 4 | 16303743 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 5.93e-04 | 205 | 28 | 3 | 12040188 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 6.52e-04 | 499 | 28 | 4 | 22810586 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 7.18e-04 | 219 | 28 | 3 | 12213199 | |
| Interaction | SLC44A1 interactions | 3.13e-05 | 46 | 27 | 3 | int:SLC44A1 | |
| Interaction | SCN10A interactions | 9.44e-05 | 11 | 27 | 2 | int:SCN10A | |
| Interaction | SARAF interactions | 1.44e-04 | 202 | 27 | 4 | int:SARAF | |
| Interaction | SCN11A interactions | 1.80e-04 | 15 | 27 | 2 | int:SCN11A | |
| Interaction | SCN8A interactions | 3.24e-04 | 20 | 27 | 2 | int:SCN8A | |
| Interaction | SYNGR1 interactions | 4.10e-04 | 109 | 27 | 3 | int:SYNGR1 | |
| Interaction | POMK interactions | 4.40e-04 | 271 | 27 | 4 | int:POMK | |
| Interaction | P2RY2 interactions | 4.43e-04 | 112 | 27 | 3 | int:P2RY2 | |
| Interaction | CACNA1D interactions | 4.68e-04 | 24 | 27 | 2 | int:CACNA1D | |
| Interaction | TSPAN15 interactions | 4.71e-04 | 276 | 27 | 4 | int:TSPAN15 | |
| Interaction | SLC29A1 interactions | 5.56e-04 | 121 | 27 | 3 | int:SLC29A1 | |
| Interaction | TMEM268 interactions | 5.94e-04 | 27 | 27 | 2 | int:TMEM268 | |
| Interaction | ABHD6 interactions | 5.94e-04 | 27 | 27 | 2 | int:ABHD6 | |
| Interaction | SLC12A6 interactions | 5.97e-04 | 124 | 27 | 3 | int:SLC12A6 | |
| Cytoband | 19p13.1 | 3.45e-06 | 48 | 28 | 3 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.32e-03 | 797 | 28 | 4 | chr19p13 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.72e-07 | 9 | 24 | 3 | 1203 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.24e-06 | 26 | 24 | 3 | 253 | |
| GeneFamily | Olfactory receptors, family 10 | 8.90e-05 | 66 | 24 | 3 | 157 | |
| GeneFamily | Solute carriers | 1.46e-04 | 395 | 24 | 5 | 752 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 2.96e-05 | 773 | 26 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.82e-05 | 336 | 26 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.44e-05 | 12 | 26 | 2 | gudmap_kidney_P0_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_100 | 1.90e-04 | 92 | 26 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.94e-04 | 17 | 26 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 2.89e-04 | 777 | 26 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.58e-06 | 168 | 28 | 4 | 9adb91ae87a009db7ed83e0d3ab964acc38708f1 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 190 | 28 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 190 | 28 | 4 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 190 | 28 | 4 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 194 | 28 | 4 | c422aeddb4e949a22f731da675bdf91dee86ba61 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.37e-05 | 136 | 28 | 3 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.72e-05 | 143 | 28 | 3 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 145 | 28 | 3 | 78f5f4b96420c7f391e4d32a9ed151ed95fad90b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-04 | 145 | 28 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 149 | 28 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 1.23e-04 | 155 | 28 | 3 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 160 | 28 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 161 | 28 | 3 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 163 | 28 | 3 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.56e-04 | 168 | 28 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.56e-04 | 168 | 28 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 169 | 28 | 3 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 172 | 28 | 3 | 65b8935a972bf00b7a10dc2d442128fc0ed78bcb | |
| ToppCell | ILEUM-inflamed-(4)_Mast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.68e-04 | 172 | 28 | 3 | be82f749f4b1049ae8832facc052082cf5463c11 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 172 | 28 | 3 | a7fd4d61fb5017dce001d69d6b9a01e6cdf58828 | |
| ToppCell | ILEUM-inflamed-(4)_Mast_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.68e-04 | 172 | 28 | 3 | 7185b28282412f3a464b2a8ad5605475a1a31358 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.73e-04 | 174 | 28 | 3 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 174 | 28 | 3 | 3f4277763e312b46ebd4401ea4a2f5d4c850c768 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 174 | 28 | 3 | fad66d1a8407574b6a835e0bdb824a53afa58650 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-04 | 175 | 28 | 3 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-04 | 175 | 28 | 3 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 177 | 28 | 3 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 177 | 28 | 3 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | 3d6bb3cfe89d60f2f00aead9341f9967e5313763 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 1.89e-04 | 179 | 28 | 3 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-04 | 180 | 28 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-04 | 180 | 28 | 3 | 410ea13a9c00cf54b4d47c72404dfe893c086d87 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 181 | 28 | 3 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-04 | 182 | 28 | 3 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-04 | 183 | 28 | 3 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 183 | 28 | 3 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.14e-04 | 187 | 28 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.14e-04 | 187 | 28 | 3 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 188 | 28 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 28 | 3 | 70184b14160b71a1fecd7f195e5a16c5937738a2 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | 7c6d586f352d0d44c24079e76272cb3a545441b5 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | 5438baaa3056fec46d59f75f03f27a93601936c1 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 992539c380576bf810c00a5f926cf1ee7d57dcf5 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-04 | 190 | 28 | 3 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-04 | 191 | 28 | 3 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-04 | 192 | 28 | 3 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-04 | 192 | 28 | 3 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Disease group,lineage and cell class （2021.01.30） | 2.32e-04 | 192 | 28 | 3 | 1da7c303a2e36af4a9d8ec30a11380d9b1897922 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | 735a72fac16397edde95e8eefa6f83caeb5ee5df | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 193 | 28 | 3 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | 0ca0439dfdcb2361ca8d1015fb874a5b5c635d31 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | d08919db9601941569b9a143dad4d8e6f56a4389 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | ff901d2f3d7a511639c1e3b76058896c0d8a8602 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.35e-04 | 193 | 28 | 3 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | 124364adb3ded77282d449dd2cb039e6f2403a39 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 9a5dd7ae6de72a000cf9a0d42f6b0884fa43f345 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 34b54bea013c8c724fadae357e29953c291bfce1 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 195 | 28 | 3 | f9a90cd7b4e99a0947fdb3645f7787d02b0f7ca0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-04 | 196 | 28 | 3 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 196 | 28 | 3 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 2.46e-04 | 196 | 28 | 3 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.50e-04 | 197 | 28 | 3 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.50e-04 | 197 | 28 | 3 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-04 | 198 | 28 | 3 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Smooth_Muscle_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.57e-04 | 199 | 28 | 3 | 31c781a1787e5140fb3f611823cbab4d13d02dfa | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-H|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.61e-04 | 200 | 28 | 3 | 0ebc54d19873a2b7b6d12b81559cb12abd73b90c | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Fos_(dSPN,_IEG+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.64e-04 | 45 | 28 | 2 | cce61a18a2d2ac9c3113ef7d9fe8adf70bad773c | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Fos_(dSPN,_IEG+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.64e-04 | 45 | 28 | 2 | 08e956e0a428432382ecc13f293f20154fac042c | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.01e-03 | 75 | 28 | 2 | 3bc5df14f21c1c93c2a0fd5fc47bc5d146ba87a2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-03 | 88 | 28 | 2 | 3a92f76e4db86486cb265301e6056af791a11a63 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-7|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.78e-03 | 100 | 28 | 2 | 7a0220df4020aeb16fecbbe9b46f3ccf86c62dd8 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.92e-03 | 104 | 28 | 2 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.92e-03 | 104 | 28 | 2 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.92e-03 | 104 | 28 | 2 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 113 | 28 | 2 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 113 | 28 | 2 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 113 | 28 | 2 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-03 | 115 | 28 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-03 | 115 | 28 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-03 | 115 | 28 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-03 | 118 | 28 | 2 | 3cebd17f4688cd43fe1283dc60957e87d5536810 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-03 | 118 | 28 | 2 | 71f63efc641cd07c870f7695118fb244929c1536 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-03 | 118 | 28 | 2 | 61b00b001edb1954a5fffaf4dfe71708124a45e5 | |
| Computational | Genes in the cancer module 71. | 3.08e-04 | 22 | 13 | 2 | MODULE_71 | |
| Drug | lamotrigine | SCN10A CACNA1S CACNA1H CACNA1G SLC43A3 SCN4A SCN5A SCN7A TPCN1 | 1.07e-14 | 116 | 28 | 9 | CID000003878 |
| Drug | bepridil | 1.99e-12 | 126 | 28 | 8 | CID000002351 | |
| Drug | gabapentin | 2.14e-11 | 169 | 28 | 8 | CID000003446 | |
| Drug | isradipine | 2.80e-11 | 100 | 28 | 7 | CID000003784 | |
| Drug | NSC7524 | 3.87e-11 | 182 | 28 | 8 | CID000005657 | |
| Drug | phenytoin | 1.70e-10 | 219 | 28 | 8 | CID000001775 | |
| Drug | procaine | 5.67e-10 | 153 | 28 | 7 | CID000004914 | |
| Drug | riluzole | 1.39e-09 | 174 | 28 | 7 | CID000005070 | |
| Drug | pyraclofos | 3.06e-09 | 106 | 28 | 6 | CID000093460 | |
| Drug | Zonisamide | 4.31e-09 | 17 | 28 | 4 | DB00909 | |
| Drug | sodium | SCN10A CACNA1S CACNA1H SLC43A3 MCHR1 SLC13A2 SLC16A2 SCN4A SCN5A SCN7A TPCN1 | 6.60e-09 | 944 | 28 | 11 | CID000000923 |
| Drug | zonisamide | 1.19e-08 | 62 | 28 | 5 | CID000005734 | |
| Drug | AC1L1MOZ | 3.15e-08 | 27 | 28 | 4 | CID000031958 | |
| Drug | tocainide | 4.90e-08 | 30 | 28 | 4 | CID000038945 | |
| Drug | oxcarbazepine | 4.90e-08 | 30 | 28 | 4 | CID000034312 | |
| Drug | carbamazepine | 7.09e-08 | 179 | 28 | 6 | CID000002554 | |
| Drug | verapamil | 9.25e-08 | 490 | 28 | 8 | CID000002520 | |
| Drug | Cinnarizine | 1.39e-07 | 9 | 28 | 3 | DB00568 | |
| Drug | Mibefradil | 2.73e-07 | 11 | 28 | 3 | DB01388 | |
| Drug | pilsicainide | 2.88e-07 | 46 | 28 | 4 | CID000004820 | |
| Drug | tetralol | 4.72e-07 | 13 | 28 | 3 | CID000010747 | |
| Drug | Cinildipine | 6.43e-07 | 56 | 28 | 4 | CID000002752 | |
| Drug | isovalerate | 7.97e-07 | 143 | 28 | 5 | CID000010430 | |
| Drug | nilvadipine | 8.51e-07 | 60 | 28 | 4 | CID000004494 | |
| Drug | Verapamil | 9.23e-07 | 16 | 28 | 3 | DB00661 | |
| Drug | lercanidipine | 1.04e-06 | 63 | 28 | 4 | CID000065866 | |
| Drug | mibefradil | 1.10e-06 | 64 | 28 | 4 | CID000060662 | |
| Drug | AC1L1CQC | 1.18e-06 | 65 | 28 | 4 | CID000002012 | |
| Drug | mexiletine | 1.25e-06 | 66 | 28 | 4 | CID000004178 | |
| Drug | disopyramide | 1.25e-06 | 66 | 28 | 4 | CID000003114 | |
| Drug | gallopamil | 1.33e-06 | 67 | 28 | 4 | CID000001234 | |
| Drug | lidocaine | 1.39e-06 | 160 | 28 | 5 | CID000003676 | |
| Drug | dibucaine | 1.41e-06 | 68 | 28 | 4 | CID000003025 | |
| Drug | Hexylcaine | 1.46e-06 | 2 | 28 | 2 | DB00473 | |
| Drug | Flecainide | 1.46e-06 | 2 | 28 | 2 | DB01195 | |
| Drug | GBR 12909 | 1.50e-06 | 69 | 28 | 4 | CID000003455 | |
| Drug | AC1L2AC7 | 1.50e-06 | 69 | 28 | 4 | CID000068733 | |
| Drug | diprafenone | 1.59e-06 | 19 | 28 | 3 | CID000071249 | |
| Drug | flecainide | 1.68e-06 | 71 | 28 | 4 | CID000003355 | |
| Drug | CAS 298-57-7 | 1.88e-06 | 73 | 28 | 4 | CID000002761 | |
| Drug | ethosuximide | 1.98e-06 | 74 | 28 | 4 | CID000003291 | |
| Drug | potassium | 2.03e-06 | 1008 | 28 | 9 | CID000000813 | |
| Drug | nisoldipine | 2.45e-06 | 78 | 28 | 4 | CID000004499 | |
| Drug | dihydropyridine | 3.49e-06 | 193 | 28 | 5 | CID000104822 | |
| Drug | AC1NT1AF | 3.76e-06 | 25 | 28 | 3 | CID005322157 | |
| Drug | Pirmenolum | 4.25e-06 | 26 | 28 | 3 | CID000004853 | |
| Drug | Dibucaine | 4.37e-06 | 3 | 28 | 2 | DB00527 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 4.37e-06 | 3 | 28 | 2 | CID010679219 | |
| Drug | nefopam | 4.78e-06 | 27 | 28 | 3 | CID000004450 | |
| Drug | PbTx-1 | 4.78e-06 | 27 | 28 | 3 | CID006437089 | |
| Drug | paraben | 5.35e-06 | 28 | 28 | 3 | CID000007175 | |
| Drug | manidipine | 5.39e-06 | 95 | 28 | 4 | CID000004008 | |
| Drug | GTP[S] | 5.65e-06 | 591 | 28 | 7 | CID000001764 | |
| Drug | valproate | 5.82e-06 | 381 | 28 | 6 | CID000003121 | |
| Drug | propafenone | 6.10e-06 | 98 | 28 | 4 | CID000004932 | |
| Drug | nitrendipine | 6.10e-06 | 98 | 28 | 4 | CID000004507 | |
| Drug | loperamide | 8.03e-06 | 105 | 28 | 4 | CID000003954 | |
| Drug | NSC93767 | 8.07e-06 | 32 | 28 | 3 | CID000005658 | |
| Drug | Lidocaine | 8.74e-06 | 4 | 28 | 2 | DB00281 | |
| Drug | CNS 1145 | 8.87e-06 | 33 | 28 | 3 | CID000190902 | |
| Drug | IHC-64 | 8.87e-06 | 33 | 28 | 3 | CID000162753 | |
| Drug | 5-hydroxypropafenone | 9.72e-06 | 34 | 28 | 3 | CID000107927 | |
| Drug | tetradotoxin | 1.13e-05 | 428 | 28 | 6 | CID000020382 | |
| Drug | benzocaine | 1.26e-05 | 37 | 28 | 3 | CID000002337 | |
| Drug | aprindine | 1.37e-05 | 38 | 28 | 3 | CID000002218 | |
| Drug | Flunarizine | 1.46e-05 | 5 | 28 | 2 | DB04841 | |
| Drug | S-ropivacaine | 1.60e-05 | 40 | 28 | 3 | CID000071273 | |
| Drug | amlodipine | 1.65e-05 | 126 | 28 | 4 | CID000002162 | |
| Drug | pimozide | 1.70e-05 | 127 | 28 | 4 | CID000016362 | |
| Drug | APETx1, Anthopleura elegantissima | 2.18e-05 | 6 | 28 | 2 | ctd:C475726 | |
| Drug | 3,4-dihydroquinazoline | 2.18e-05 | 6 | 28 | 2 | CID000583065 | |
| Drug | lanthanum | 2.23e-05 | 136 | 28 | 4 | CID000023926 | |
| Drug | spiradoline | 2.44e-05 | 46 | 28 | 3 | CID000005620 | |
| Drug | Dantrolene-13C3 | 2.87e-05 | 145 | 28 | 4 | CID000002951 | |
| Drug | nimodipine | 2.87e-05 | 145 | 28 | 4 | CID000004497 | |
| Drug | nicardipine | 2.87e-05 | 145 | 28 | 4 | CID000004473 | |
| Drug | indoxacarb | 2.95e-05 | 49 | 28 | 3 | CID000107720 | |
| Drug | Isradipine | 3.05e-05 | 7 | 28 | 2 | DB00270 | |
| Drug | LY215840 | 3.05e-05 | 7 | 28 | 2 | CID000132049 | |
| Drug | KW-3049 | 3.14e-05 | 50 | 28 | 3 | CID000002324 | |
| Drug | Bay K 8644 | 3.28e-05 | 150 | 28 | 4 | CID000002303 | |
| Drug | AC1NSN3X | 3.96e-05 | 54 | 28 | 3 | CID005366189 | |
| Drug | Nitrendipine | 4.07e-05 | 8 | 28 | 2 | DB01054 | |
| Drug | Cocaine | 4.07e-05 | 8 | 28 | 2 | DB00907 | |
| Drug | Nifedipine | 4.07e-05 | 8 | 28 | 2 | DB01115 | |
| Drug | amiodarone | 4.22e-05 | 160 | 28 | 4 | CID000002156 | |
| Drug | triamterene | 4.91e-05 | 58 | 28 | 3 | CID000005546 | |
| Drug | felodipine | 5.22e-05 | 169 | 28 | 4 | CID000003333 | |
| Drug | Mexiletine | 5.22e-05 | 9 | 28 | 2 | ctd:D008801 | |
| Drug | cyclaine | 5.22e-05 | 9 | 28 | 2 | CID000010770 | |
| Drug | Landel | 5.22e-05 | 9 | 28 | 2 | CID000163838 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 5.54e-05 | 568 | 28 | 6 | CID000000806 | |
| Drug | IAA-94 | 5.72e-05 | 61 | 28 | 3 | CID000003667 | |
| Drug | fenfluramine | 6.39e-05 | 178 | 28 | 4 | CID000003337 | |
| Drug | saxitoxin | 6.91e-05 | 65 | 28 | 3 | CID000037165 | |
| Drug | resiniferatoxin | 7.24e-05 | 66 | 28 | 3 | CID000104826 | |
| Drug | Felodipine | 7.97e-05 | 11 | 28 | 2 | DB01023 | |
| Drug | EBNs | 7.97e-05 | 11 | 28 | 2 | CID000150695 | |
| Drug | norketamine | 7.97e-05 | 11 | 28 | 2 | CID000123767 | |
| Drug | procainamide | 8.22e-05 | 190 | 28 | 4 | CID000004913 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.16e-10 | 10 | 27 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.16e-10 | 10 | 27 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.74e-10 | 12 | 27 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.54e-07 | 163 | 27 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 | 8.06e-07 | 2 | 27 | 2 | 170400 | |
| Disease | Hypokalemic periodic paralysis, type 1 | 8.06e-07 | 2 | 27 | 2 | cv:C3714580 | |
| Disease | Hypokalemic periodic paralysis | 8.06e-07 | 2 | 27 | 2 | cv:C0238358 | |
| Disease | bone structure disease (implicated_via_orthology) | 8.06e-07 | 2 | 27 | 2 | DOID:0080010 (implicated_via_orthology) | |
| Disease | Hypokalemic periodic paralysis type 1 | 2.42e-06 | 3 | 27 | 2 | C3714580 | |
| Disease | Brugada ECG Pattern | 4.83e-06 | 4 | 27 | 2 | C1721096 | |
| Disease | Hypokalemic periodic paralysis | 4.83e-06 | 4 | 27 | 2 | C0238358 | |
| Disease | electrocardiography, PR interval | 1.69e-05 | 7 | 27 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 2.25e-05 | 8 | 27 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | supraventricular ectopy | 2.89e-05 | 9 | 27 | 2 | EFO_0009277 | |
| Disease | Congenital myopathy (disorder) | 5.29e-05 | 12 | 27 | 2 | C0270960 | |
| Disease | Brugada Syndrome 1 | 6.25e-05 | 13 | 27 | 2 | C4551804 | |
| Disease | T wave morphology measurement | 7.29e-05 | 14 | 27 | 2 | EFO_0008398 | |
| Disease | P wave duration | 8.40e-05 | 15 | 27 | 2 | EFO_0005094 | |
| Disease | Romano-Ward Syndrome | 9.60e-05 | 16 | 27 | 2 | C0035828 | |
| Disease | Brugada syndrome | 1.37e-04 | 19 | 27 | 2 | MONDO_0015263 | |
| Disease | Brugada Syndrome (disorder) | 2.20e-04 | 24 | 27 | 2 | C1142166 | |
| Disease | cardiovascular age measurement | 3.22e-04 | 29 | 27 | 2 | EFO_0803380 | |
| Disease | migraine disorder, glucose measurement | 3.69e-04 | 31 | 27 | 2 | EFO_0004468, MONDO_0005277 | |
| Disease | heart function measurement | 4.44e-04 | 34 | 27 | 2 | EFO_0004311 | |
| Disease | QRS complex, QRS duration | 7.79e-04 | 45 | 27 | 2 | EFO_0005054, EFO_0005055 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLIFMMLLAPIIHAF | 6 | Q9HAR2 | |
| AVILFFVPLMHQRMF | 491 | P36021 | |
| ILFLLPLMVMLILYS | 221 | Q96P65 | |
| PHLQLMLFLLFLLMY | 21 | Q8NGA6 | |
| PHLQLMLFLLFLLMY | 21 | O60403 | |
| MMPLLSLIFSALFIL | 536 | Q9Y2G8 | |
| AFLRHKMTLISPLML | 236 | O75164 | |
| MIAFLLTSVLMIPHA | 1 | Q02509 | |
| LLMLFIFIFSILGMH | 871 | O43497 | |
| KAMLPLFHIALLVLF | 191 | Q13698 | |
| VVDLLFLLGMPFMIH | 156 | Q99705 | |
| IAMAMSLLFIILLRF | 241 | Q8IWA5 | |
| LLMLFIFIFSILGMH | 921 | O95180 | |
| LAVTALFPLILFPMM | 56 | Q13183 | |
| MALMFTGHLLFLALL | 1 | Q8IZU8 | |
| PHLQLMLFLLFLLMY | 21 | Q9Y4A9 | |
| LMFMHLSPILLLSLN | 436 | P03905 | |
| MVELMFPLLLLLLPF | 1 | Q8TC12 | |
| LLFALMMSLPALFNI | 1471 | P35499 | |
| FQMLHLVFILPSLML | 16 | Q63ZE4 | |
| LLFALMMSLPALFNI | 1646 | Q14524 | |
| MFMLAILLTFFHPFL | 461 | Q8NBI5 | |
| GRVLLVLMFMTLLHF | 161 | O15260 | |
| LLFALMMSLPALFNI | 1596 | Q9Y5Y9 | |
| PFMDILLLLLFFMII | 231 | Q9ULQ1 | |
| LQQMFMPLLHAIFEV | 761 | O43592 | |
| FHNLMLPLMLSLPAL | 1366 | Q01118 | |
| MLMPVHFLLLLLLLL | 1 | Q969E3 | |
| MIPFLPMFSLLLLLI | 1 | Q15063 |